Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma


Por: Jimenez-Fonseca, P, Saez, JMG, Sandi, JS, Capdevila, J, Gonzalez, EN, Llopis, CZ, Asensio, TRYC, Riesco-Eizaguirre, G, Grande, E, Galofre, JC

Publicada: 1 ene 2017
Resumen:
Anaplastic thyroid cancer (ATC) is the most aggressive solid tumor and almost uniformly lethal in humans. The Boards of the Thyroid Cancer Group of the Spanish Society of Endocrinology and Nutrition and the Grupo Espaol de Enfermedades Hu,rfanas e Infrecuentes of the Spanish Society of Oncology requested that an independent task force draft a more comprehensive consensus statement regarding ATC. All relevant literature was reviewed, including serial PubMed searches together with additional articles. This is the first, comprehensive Spanish consensus statement for ATC and includes the characteristics, diagnosis, initial evaluation, treatment goals, recommendations and modalities for locoregional and advanced disease, palliative care options, surveillance, and long-term monitoring. Newer systemic therapies are being investigated, but more effective combinations are needed to improve patient outcomes. Though more aggressive radiotherapy has reduced locoregional recurrences, median overall survival has not improved in more than 50 years.

Filiaciones:
Jimenez-Fonseca, P:
 Hosp Univ Cent Asturias, Med Oncol Serv, Ave Roma Sn, Oviedo 33011, Spain

Saez, JMG:
 Hosp Univ Bellvitge, Endocrinol & Nutr Serv, CIBERDEM, Barcelona, Spain

Sandi, JS:
 Hosp Univ Cruces, Endocrinol & Nutr Serv, Vizcaya, Spain

Capdevila, J:
 Hosp Univ Vall dHebron, Med Oncol Serv, Barcelona, Spain

Gonzalez, EN:
 Hosp Univ Virgen del Rocio, Endocrinol & Nutr Serv, Seville, Spain

Llopis, CZ:
 Hosp Univ Vall dHebron, Endocrinol & Nutr Serv, Barcelona, Spain

Asensio, TRYC:
 Hosp Santa Creu & Sant Pau, Med Oncol Serv, Barcelona, Spain

Riesco-Eizaguirre, G:
 Hosp Univ Mostoles, Endocrinol & Nutr Serv, Madrid, Spain

Grande, E:
 Hosp Univ Ramon & Cajal, Med Oncol Serv, Madrid, Spain

Galofre, JC:
 Univ Navarra Clin, Endocrinol & Nutr Serv, Pamplona, Spain
ISSN: 1699048X





Clinical & Translational Oncology
Editorial
SPRINGER INTERNATIONAL PUBLISHING AG, GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND, España
Tipo de documento: Review
Volumen: 19 Número: 1
Páginas: 12-20
WOS Id: 000392293000002
ID de PubMed: 27048161

MÉTRICAS